HUM

Humana Inc
NYSEHEALTHCAREHEALTHCARE PLANS

Key Statistics

Market Cap
$52.08B
P/E Ratio
38.94
EPS
$11.14
Beta
0.64
52W High
$455.53
52W Low
$161.56
50-Day MA
$404.07
200-Day MA
$311.98
Dividend Yield
0.00%
Profit Margin
0.88%
Forward P/E
25.84
PEG Ratio
1.14

About Humana Inc

Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$145.68B
Gross Profit (TTM)$19.89B
EBITDA$3.60B
Operating Margin3.46%
Return on Equity6.89%
Return on Assets3.90%
Revenue/Share (TTM)$1211.44
Book Value$146.42
Price-to-Book2.57
Price-to-Sales (TTM)0.36
EV/Revenue0.39
EV/EBITDA—
Quarterly Earnings Growth (YoY)27.10%
Quarterly Revenue Growth (YoY)26.20%
Shares Outstanding$120.08M
Float$119.83M
% Insiders0.21%
% Institutions101.31%

Historical Volatility

HV 10-Day
31.98%
HV 20-Day
32.88%
HV 30-Day
45.29%
HV 60-Day
36.80%
HV Rank
71.0%

Volatility is currently contracting

Analyst Ratings

Consensus ($465.12 target)
2
Strong Buy
11
Buy
12
Hold
1
Sell

Latest News

Humana (HUM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research11/6/2026Neutral
Diamond Hill Large Cap Fund Q3 2026 Portfolio Update

The Fund returned 3.18% compared to a 2.61% return for the Russell 1000 Value Index. Key contributors include Microsoft, Salesforce and Thermo Fisher Scientific. Key detractors include Aon, Carrier Global and Builders FirstSource.

Seeking Alpha11/6/2026Positive
Humana (HUM) Reports Q3 Loss, Beats Revenue Estimates

Humana (HUM) came out with a quarterly loss of $0.7 per share versus the Zacks Consensus Estimate of a loss of $1.03. This compares to earnings of $3.24 per share a year ago.

Zacks Investment Research11/6/2026Neutral
Humana Reports Third Quarter 2026 Financial Results; Raises Full Year 2026 Adjusted EPS Guidance

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share for the quarter ended September 30, 2026 (3Q26) versus the quarter ended September 30, 2025 (3Q25) and for the nine months ended September 30, 2026 (YTD 2026) versus the nine months ended September 30, 2025 (YTD 2025) as noted in the tables below. Consolidated income (loss) before income taxes and equity in net losses (pretax results) In millions 3Q26 (a) 3Q25 (a).

Business Wire11/6/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HUM and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026